Helicobacter Pylori Testing Market Size

Helicobacter Pylori Testing Market size was valued at USD 483 million in 2023 and is anticipated to witness growth at a CAGR of 6.8% from 2024 to 2032. The high market growth is attributed to rising prevalence of various gastrointestinal disorders, growing demand for point of care testing, and increasing adoption of non-invasive helicobacter pylori testing among others.

The rise in the prevalence of gastric ulcers is a key driver for the growth of helicobacter pylori (H. pylori) testing market. Gastric ulcers, frequently caused by H. pylori infection, are becoming more common due to factors such as increased stress, smoking, and the overuse of nonsteroidal anti-inflammatory drugs (NSAIDs). As the incidence of gastric ulcers rises, there is a heightened demand for diagnostic testing to accurately identify the presence of H. pylori. For instance, according to the data published by American Gastroenterological Association’s (AGA) Clinical Practice Update, Diagnosis and Treatment of Helicobacter pylori Infection in 2021 stated that H. pylori is found in 70-90% of patients with peptic ulcers. This data supports the critical need for H. pylori testing in managing ulcer-related conditions.

Helicobacter pylori (H. pylori) testing refers to a series of diagnostic procedures used to detect the presence of the H. pylori bacterium in the gastrointestinal tract. This bacterium is commonly associated with various stomach conditions, including peptic ulcers, chronic gastritis, and in some cases, gastric cancer. Testing helps in diagnosing active infections, guiding appropriate treatment, and monitoring the effectiveness of therapy.